Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Poland

Marie Skłodowska-Curie Action · Running

MITGEST Quality Control of the Mitochondrial Gene Expression System in Health and Disease

Coordinator
Miedzynarodowy Instytut Mechanizmow I Maszyn Molekularnych Polskiej Akademii Nauk, Poland
Runs
1 October 2022 to 31 January 2027
Status
Running
EU funding
€2.6m
Total cost
—
Partners
26 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101072515

What the project is doing

In the project's own words, from its summary on CORDIS.

Mitochondria produce most of the energy the body acquires through food, and are thus pivotal players in cellular metabolism. Central to mitochondrial biology is the DNA in the organelle (mtDNA): its maintenance, correct RNA processing, and efficient translation are all essential and must be coordinated to ensure proper mitochondrial function and cellular physiology. Defective maintenance or expression of mtDNA alters energy and nutrient metabolism, which are increasingly recognized to impact medical disciplines, ranging from hundreds of genetic disorders to neurodegeneration, immunology, transmissible disease, cancer and ageing.

A deep understanding of the mitochondrial gene expression system and new methods are urgently needed to develop treatments for the full panoply of mitochondrial disorders that feature mtDNA perturbation. MITGEST will unite world-class academic excellence in mtDNA maintenance and expression with private sector expertise in nucleic acid chemistry and the development of mitochondrial therapeutics to address this urgent need.

As the first research training programme in this field to take a fully integrated approach, our 10 doctoral candidates (DC) will elucidate how mtDNA is maintained and expressed and support the development of new methods to analyse RNA and DNA metabolism in mitochondria. These advances will complement and facilitate/enhance innovative treatment strategies and experimental medicine studies designed to mitigate mitochondrial dysfunction in a range of human diseases.

Our network of 7 beneficiaries and 12 associated partners from 8 European countries and Israel builds on proven collaborations and establishes new partnerships to deliver intersectoral and multidisciplinary scientific and transferable skills training to our 11 PhD students to generate the next generation of highly-skilled scientists able to exploit the latest advances in mitochondrial biology and medicine.

Topics

Who is involved

OrganisationCityCountryRole
Miedzynarodowy Instytut Mechanizmow I Maszyn Molekularnych Polskiej Akademii NaukWarszawaPolandCoordinator
Accelopment Schweiz AGZurichSwitzerlandAssociatedpartner
Baseclick GmbHNeuriedGermanyParticipant
Johann Wolfgang Goethe-Universitaet Frankfurt Am MainFrankfurt Am MainGermanyAssociatedpartner
4basebio SLMadridSpainAssociatedpartner
Asociacion Instituto De Investigacion Sanitaria BiogipuzkoaDonostia-San SebastianSpainParticipant
Universidad Del Pais Vasco/ Euskal Herriko UnibertsitateaLeioaSpainAssociatedpartner
Minovia TherapeuticsTirat HacarmelIsraelAssociatedpartner
Minovia TherapeuticsTirat HacarmelIsraelParticipant
Technion - Israel Institute of TechnologyHaifaIsraelAssociatedpartner
Technion Research and Development Foundation LtdHaifaIsraelParticipant
Agilent Technologies Italia SpACernusco Sul NaviglioItalyAssociatedpartner
Mitocon - Insieme per Lo Studio E La Cura Delle Malattie Mitocondriali - OdvRomaItalyAssociatedpartner
Universita Degli Studi Di PaviaPaviaItalyAssociatedpartner
Universita Degli Studi Di UdineUdineItalyAssociatedpartner
Universita Degli Studi Di UdineUdineItalyParticipant
Lumicks BVAmsterdamNetherlandsAssociatedpartner
Predica Diagnostics BVNijmegenNetherlandsAssociatedpartner
Stichting Radboud Universitair Medisch CentrumNijmegenNetherlandsParticipant
Stichting Radboud UniversiteitNijmegenNetherlandsAssociatedpartner
Instytut Biochemii I Biofizyki Polskiej Akademii NaukWarszawaPolandParticipant
Instytut Chemii Bioorganicznej Polskiej Akademii NaukPoznanPolandAssociatedpartner
Karolinska InstitutetStockholmSwedenParticipant
Careers Research and Advisory Centre (crac) Limited (the)CambridgeUnited KingdomAssociatedpartner
The Lily FoundationWarlinghamUnited KingdomAssociatedpartner
University College LondonLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI